JDD Highlights
The October issue of the Journal of Drugs in Dermatology is available now. This month, we focus on atopic dermatitis with special features on Public Health, Anti-aging, Aesthetic, and Medical Dermatology.
Read the October JDD Now
Atopic Dermatitis, Public Health, Anti-Aging, and Medical Dermatology
The October issue of the Journal of Drugs in Dermatology is available now. This month, we focus on atopic dermatitis, with special features on Public Health, Anti-aging, Aesthetic, and Medical Dermatology.
Article Highlights
- Clinical Relevance of Skin Pain in Atopic Dermatitis discusses the clinical relevance of skin pain with respect to its experience, pathophysiology, relationship with itch, and treatment implications.
- A roundtable discussion was held to discuss overall and specific strategies for treating rosacea in Rationale for Use of Combination Therapy in Rosacea
- Results from an expert panel were summarized and discussed to provide updated recommendations for the treatment and maintenance of AD in Atopic Dermatitis and the Role of the Skin Microbiome in Choosing Prevention, Treatment, and Maintenance Options
- Impact of Atopic Dermatitis Lesion Location on Quality of Life in Adult Patients in a Real-world Study reports the impact of specific AD lesion locations on QoL in adult patients with AD using real-world data
Editor's Picks
- IncobotulinumtoxinA Demonstrates Safety and Prolonged Duration of Effect in a Dose-Ranging Study for Glabellar Lines
- Hyaluronidase in Dermatology: Uses Beyond Hyaluronic Acid Fillers
You May Also Like
Wound Care Is Trending: A JDD Vault Pick on Bensal HP and Repair This is a must-read article from JDD. Wound care is a hot topic in dermatology and that is…
The U.S. Food & Drug Administration (FDA) recently adopted changes to the approvals of two medications for inflammatory skin diseases. Ebglyss (lebrikizumab-lbkz) has a newly approved regimen of one maintenance…
Guest: Dr. Andrew Blauvelt Not all psoriasis data tell the same story, and sometimes the loudest signal isn't the most important one. In this episode of the JDD Podcast, host…
